世界のタンパク質シーケンシング市場2022-2030:製品&サービス別(タンパク質シーケンシング製品、タンパク質シーケンシングサービス)、用途別、エンドユーザー別

【英語タイトル】Protein Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Protein Sequencing Products, Protein Sequencing Services), By Application, By End-user, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22NV073)・商品コード:GRV22NV073
・発行会社(調査会社):Grand View Research
・発行日:2022年10月4日
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社は、世界のタンパク質シーケンシング市場規模が、2022年から2030年の間に年平均3.5%成長し、2030年までに17.7億ドルに達すると予測しています。当調査レポートでは、タンパク質シーケンシングの世界市場について総合的に調査・分析を行い、調査手法、エグゼクティブサマリー、市場変動・動向・範囲、製品&サービス別(タンパク質シーケンシング製品、タンパク質シーケンシングサービス)分析、用途別(生物療法、遺伝子工学、その他)分析、エンドユーザー別(学術機関&研究センター、製薬&バイオテクノロジー企業、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの構成でまとめています。なお、当書に掲載されている企業情報には、Thermo Fisher Scientific, Inc.、Shimadzu Corporation、Agilent Technologies, Inc.、Rapid Novor, Inc.、Charles River Laboratories、Proteome Factory AG、Selvita、Bioinformatics Solutions Inc.、Creative Proteomics、Alphalyse、Brukerなどが含まれています。
・調査手法
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界のタンパク質シーケンシング市場規規模:製品&サービス別
- タンパク質シーケンシング製品の市場規模
- タンパク質シーケンシングサービスの市場規模
・世界のタンパク質シーケンシング市場規規模:用途別
- 生物療法における市場規模
- 遺伝子工学における市場規模
- その他用途における市場規模
・世界のタンパク質シーケンシング市場規規模:エンドユーザー別
- 学術機関&研究センターにおける市場規模
- 製薬&バイオテクノロジー企業における市場規模
- その他エンドユーザーにおける市場規模
・世界のタンパク質シーケンシング市場規模:地域別
- 北米のタンパク質シーケンシング市場規模
- ヨーロッパのタンパク質シーケンシング市場規模
- アジア太平洋のタンパク質シーケンシング市場規模
- 中南米のタンパク質シーケンシング市場規模
- 中東・アフリカのタンパク質シーケンシング市場規模
・競争状況

Protein Sequencing Market Growth & Trends

The global protein sequencing market size is expected to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.5% from 2022 to 2030. The increasing research in genomics and proteomics, coupled with the rising demand for protein-based therapeutics around the world, is contributing to the demand for protein sequencing. For instance, in May 2022, Amphista Therapeutics announced a collaboration with Bristol Myers Squibb for discovering and developing small-molecule protein degraders. Bristol Myers Squibb is expected to receive an exclusive license to manufacture and commercialize the product. Hence, the rising demand for protein degradation is anticipated to extend the application scope for protein sequencing.

Increasing funding and grants for biomedical R&D by governments and major companies are anticipated to have a significant impact on the usage of sequencing. As per a WHO report published in January 2022, in 2019, approximately 80,178 grants were awarded to biomedical research from 11 funders. Out of those, 69.4% of grants were assigned for research, while 19.5% were for training purposes. Moreover, approximately 75% of the overall grants were awarded to organizations in the U.S. Federal funding in the U.S. has created the demand for protein sequencing from end-users.

Similarly, the usage of recombinant antibodies is growing in the management of rheumatoid arthritis, cancer, and other pathological conditions, which is likely to increase the use of protein sequencing. According to research published in February 2022, the de novo antibody sequencing through mass spectrometry techniques is feasible for numerous complicated clinical samples via endogenous sources including serum. Hence, such research is likely to increase applications of the market in the area of therapeutics.

The COVID-19 pandemic resulted in increased usage of protein sequencing in assessing the components of the COVID-19 virus, along with assessing the changes in the genome post-COVID-19. A study published in September 2022 performed 97,437 COVID-19 protein sequencing to detect non-synonymous mutations in 26 various sequences. This had a positive impact on the global market.

The growing demand for personalized medicine and vaccination is likely to be an essential factor for the market growth since it is an emerging application of the market. For instance, in January 2022, Amgen collaborated with Generate Biomedicines in order to discover and advance protein-based therapeutics for multiple fields. The collaboration is estimated to be valued at around USD 1.9 billion.

On the other hand, advancements in sampling technologies covering proteomes are expected to support the growth of the technique in the proteome market. However, the regulation on intellectual property such as patents on protein sequencing is not formally drafted. For instance, in Australia, a patent on sequencing highly depends on the jurisdiction. The lack of patenting regulations restrains academic institutions to conduct R&D on developing new technologies.

Protein Sequencing Market Report Highlights

• By product and service, the service segment is projected to register the fastest growth rate during the forecast period. This can be credited to the increased funding and grants to academic institutions, such as the University of California and Yale University, to support their research in the biomedical application of the sequencing

• By application, the bio-therapeutics segment held the largest share in 2021 and is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increase in R&D investment for developing protein-based therapeutics and strategic initiatives such as fundraising

• By end-user, the academic institutes and research centers segment held the largest share in 2021. This is owing to the presence of well-equipped facilities for research in developed countries

• North America led the market in 2021 with a revenue share of over 35.0%. This is attributed to the increasing accessibility of funding opportunities for start-ups and academic institutions, along with the existence of key players in the region

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Protein Sequencing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 The development of commercial and non-commercial antibody research
3.2.2 Increasing biomedical research to develop biomarkers
3.2.3 Rising funding by government for proteomics and genomics research
3.3 Market Restraint Analysis
3.3.1 High maintenance of equipment
3.4 Protein Sequencing – SWOT Analysis, By Factor (political & legal, economic and technological)
3.5 Industry Analysis – Porter’s
3.6 Protein Sequencing Market: Market Position Analysis, 2021
3.7 COVID-19 Impact Analysis
Chapter 4 Protein Sequencing Market: Product and Service Estimates & Trend Analysis
4.1 Protein Sequencing Market: Product and Service Movement Analysis
4.2 Protein Sequencing Products
4.2.1 Protein Sequencing Productsmarket, 2018 – 2030 (USD Million)
4.2.1.1 Reagents & Consumables market, 2018 -2030 (USD Million)
4.2.1.2 Instruments market, 2018 -2030 (USD Million)
4.2.1.2.1 Mass Spectrometry Instruments market, 2018 -2030 (USD Million)
4.2.1.2.2 Edman Degradation Sequencers market, 2018 -2030 (USD Million)
4.2.1.3 Software market, 2018 -2030 (USD Million)
4.3 Protein Sequencing Services
4.3.1 Protein Sequencing Servicesmarket, 2018 – 2030 (USD Million)
Chapter 5 Protein Sequencing Market: Application Estimates & Trend Analysis
5.1 Protein Sequencing Market: Application Movement Analysis
5.2 Bio-therapeutics
5.2.1 Bio-therapeutics market, 2018 – 2030 (USD Million)
5.3 Genetic Engineering
5.3.1 Genetic Engineering market, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Others market, 2018 – 2030 (USD Million)
Chapter 6 Protein Sequencing Market: End-user Estimates & Trend Analysis
6.1 Protein Sequencing Market: End-user Movement Analysis
6.2 Academic Institutes & Research Centers
6.2.1 Academic Institutes & Research Centersmarket, 2018 – 2030 (USD Million)
6.3 Pharmaceutical & Biotechnology Companies
6.3.1 Pharmaceutical & Biotechnology Companies market, 2018 – 2030 (USD Million)
6.4 Others
6.4.1 Others Market, 2018 – 2030 (USD Million)
Chapter 7 Protein Sequencing Market: Regional Estimates & Trend Analysis, Product and Service, Application, End-user
7.1 Protein Sequencing Market Share By Region, 2021 & 2030
7.2 North America
7.2.1 North America Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.2.2 North America Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.2.3 North America Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.2.4 U.S.
7.2.4.1 U.S. Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.2.4.2 U.S. Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.2.4.3 U.S. Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.2.5 Canada
7.2.5.1 Canada Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.2.5.2 Canada Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.2.5.3 Canada Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.3 Europe
7.3.1 Europe Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.2 Europe Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.3 Europe Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.3.4 Germany
7.3.4.1 Germany Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.4.2 Germany Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.4.3 Germany Protein Sequencing market, by end-user,2018 – 2030 (USD Million)
7.3.5 U.K.
7.3.5.1 U.K. Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.5.2 U.K. Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.5.3 U.K. Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.3.6 France
7.3.6.1 France Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.6.2 France Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.6.3 France Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.3.7 Italy
7.3.7.1 ItalyProtein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.7.2 ItalyProtein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.7.3 ItalyProtein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.3.8 Spain
7.3.8.1 SpainProtein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.3.8.2 SpainProtein Sequencing market, by application, 2018 – 2030 (USD Million)
7.3.8.3 SpainProtein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.2 Asia Pacific Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.3 Asia Pacific Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4.4 Japan
7.4.4.1 Japan Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.4.2 Japan Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.4.3 Japan Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4.5 China
7.4.5.1 China Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.5.2 China Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.5.3 China Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4.6 India
7.4.6.1 India Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.6.2 India Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.6.3 India Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4.7 South Korea
7.4.7.1 South Korea Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.7.2 South Korea Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.7.3 South Korea Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.4.8 Australia
7.4.8.1 Australia Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.4.8.2 Australia Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.4.8.3 Australia Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.5.2 Latin America Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.5.3 Latin America Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.5.4 Brazil
7.5.4.1 Brazil Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.5.4.2 Brazil Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.5.4.3 Brazil Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.5.5 Mexico
7.5.5.1 Mexico Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.5.5.2 Mexico Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.5.5.3 Mexico Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.5.6 Argentina
7.5.6.1 Argentina Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.5.6.2 Argentina Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.5.6.3 Argentina Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.6 MEA
7.6.1 MEA Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.6.2 MEA Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.6.3 MEA Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.6.4 South Africa
7.6.4.1 South Africa Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.6.4.2 South Africa Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.6.4.3 South Africa Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 Saudi Arabia Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.6.5.2 Saudi Arabia Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.6.5.3 Saudi Arabia Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
7.6.6 UAE
7.6.6.1 UAE Protein Sequencing market, by product and service, 2018 – 2030 (USD Million)
7.6.6.2 UAE Protein Sequencing market, by application, 2018 – 2030 (USD Million)
7.6.6.3 UAE Protein Sequencing market, by end-user, 2018 – 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Thermo Fisher Scientific, Inc.
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Shimadzu Corporation
8.2.2.1 Company Overview
8.2.2.2 Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 Agilent Technologies, Inc.
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Rapid Novor, Inc.
8.2.4.1 Company Overview
8.2.4.2 Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 Charles River Laboratories
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 Proteome Factory AG
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 Selvita
8.2.7.1 Company Overview
8.2.7.2 Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Bioinformatics Solutions Inc.
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Creative Proteomics
8.2.9.1 Company Overview
8.2.9.2 Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives
8.2.10 Alphalyse
8.2.10.1 Company Overview
8.2.10.2 Financial Performance
8.2.10.3 Product Benchmarking
8.2.10.4 Strategic Initiatives
8.2.11Bruker
8.2.11.1 Company Overview
8.2.11.2 Financial Performance
8.2.11.3 Product Benchmarking
8.2.11.4 Strategic Initiatives



★調査レポート[世界のタンパク質シーケンシング市場2022-2030:製品&サービス別(タンパク質シーケンシング製品、タンパク質シーケンシングサービス)、用途別、エンドユーザー別] (コード:GRV22NV073)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のタンパク質シーケンシング市場2022-2030:製品&サービス別(タンパク質シーケンシング製品、タンパク質シーケンシングサービス)、用途別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆